These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18177202)

  • 21. Recombinant protein therapeutics--success rates, market trends and values to 2010.
    Pavlou AK; Reichert JM
    Nat Biotechnol; 2004 Dec; 22(12):1513-9. PubMed ID: 15583654
    [No Abstract]   [Full Text] [Related]  

  • 22. Adoption agent.
    Peota C
    Minn Med; 2005 Mar; 88(3):8-9. PubMed ID: 15852583
    [No Abstract]   [Full Text] [Related]  

  • 23. The pharmaceutical industry and the medical profession.
    Phatak A
    Issues Med Ethics; 1998; 6(4):131-2. PubMed ID: 16267942
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug costs can be defended.
    Lee AM
    Med Mark Media; 1982 Mar; 17(3):36, 38, 40 passim. PubMed ID: 10309584
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects and role of direct-to-physician marketing in the pharmaceutical industry: an integrative review.
    Manchanda P; Honka E
    Yale J Health Policy Law Ethics; 2005; 5(2):785-822. PubMed ID: 16052900
    [No Abstract]   [Full Text] [Related]  

  • 26. A national survey of physician-industry relationships.
    Campbell EG; Gruen RL; Mountford J; Miller LG; Cleary PD; Blumenthal D
    N Engl J Med; 2007 Apr; 356(17):1742-50. PubMed ID: 17460228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biotech jostles with pharma for slice of HIV market.
    Katsnelson A
    Nat Biotechnol; 2006 Jan; 24(1):3-4. PubMed ID: 16404375
    [No Abstract]   [Full Text] [Related]  

  • 28. Aggressive drug marketing tactics trigger backlash.
    Singer E
    Nat Med; 2007 Apr; 13(4):393. PubMed ID: 17415363
    [No Abstract]   [Full Text] [Related]  

  • 29. The cost of prescription drugs: rising concerns over equity, fairness and access to essential care.
    Work DR; Domino ME
    N C Med J; 2003; 64(6):270-4. PubMed ID: 14983614
    [No Abstract]   [Full Text] [Related]  

  • 30. Personal effects. Can emotive marketing through relationships influence rational doctors' prescriptions?
    Srivastava RK
    Mark Health Serv; 2007; 27(4):29-32. PubMed ID: 18186452
    [No Abstract]   [Full Text] [Related]  

  • 31. Direct-to-consumer marketing.
    Hurst JW
    N Engl J Med; 2002 Jun; 346(25):2011; author reply 2012-3. PubMed ID: 12078709
    [No Abstract]   [Full Text] [Related]  

  • 32. US drug companies paid $15bn in fines for fraudulent marketing in past five years.
    Tanne JH
    BMJ; 2010 Dec; 341():c7360. PubMed ID: 21177361
    [No Abstract]   [Full Text] [Related]  

  • 33. Price check! An analysis of direct-to-consumer pharmaceutical marketing.
    Wakeam E
    Acad Med; 2009 Feb; 84(2):234-5. PubMed ID: 19174677
    [No Abstract]   [Full Text] [Related]  

  • 34. Marketing pharmaceutical products to physicians. Sales reps influence physicians' impressions of the industry.
    Creyer EH; Hrsistodoulakis I
    Mark Health Serv; 1998; 18(2):34-8. PubMed ID: 10180333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Key factors in the rising cost of new drug discovery and development.
    Dickson M; Gagnon JP
    Nat Rev Drug Discov; 2004 May; 3(5):417-29. PubMed ID: 15136789
    [No Abstract]   [Full Text] [Related]  

  • 36. The price of innovation: new estimates of drug development costs.
    DiMasi JA; Hansen RW; Grabowski HG
    J Health Econ; 2003 Mar; 22(2):151-85. PubMed ID: 12606142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physicians' perceptions and uses of commercial drug information sources: an examination of pharmaceutical marketing to physicians.
    Spiller LD; Wymer WW
    Health Mark Q; 2001; 19(1):91-106. PubMed ID: 11727295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cost and availability of prescription drugs--what can we do in Massachusetts?
    Carpenter NW; Kedikoglou S
    Issue Brief (Mass Health Policy Forum); 1999 May; (4):1-41. PubMed ID: 12769091
    [No Abstract]   [Full Text] [Related]  

  • 39. Following the script: how drug reps make friends and influence doctors.
    Fugh-Berman A; Ahari S
    PLoS Med; 2007 Apr; 4(4):e150. PubMed ID: 17455991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Premedical students' exposure to the pharmaceutical industry's marketing practices.
    Hodges LE; Arora VM; Humphrey HJ; Reddy ST
    Acad Med; 2013 Feb; 88(2):265-8. PubMed ID: 23269292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.